Expert Insight

6 minute read

The 3 trends reshaping the specialty drug pipeline today

Specialty drugs now dominate the pharmaceutical pipeline. Find out how rising high-cost therapies, growth in self-administered drugs, and the expansion of biosimilars are contributing to this shift.

Specialty drugs are a broad category of high-cost, complex therapies that may be administered by patients or providers and are covered under either the pharmacy or medical benefit. For more detail on what makes a drug a specialty product, specialty medication glossary.

Growing utilization and a robust pipeline have led to ballooning spending on specialty drugs in recent years. With specialty drugs making up 75% of the drug pipeline in 2024, high drug spend is likely to remain healthcare’s new normal.1

Using data from Optum Pharmacy Advisory Services' Health Technology Pipeline Tool, we identified three major trends shaping the specialty drug pipeline. These trends have and will continue to influence health plan, health system, and pharmacy benefit manager strategies within the specialty pharmacy market.


SPONSORED BY

INTENDED AUDIENCE

AFTER YOU READ THIS
  • You'll understand the major forces driving specialty drug pipeline growth.
  • You'll recognize how these trends impact different key stakeholders.
  • You'll be able to identify opportunities to manage specialty drug costs.

Don't miss out on the latest Advisory Board insights

Create your free account to access 1 resource, including the latest research and webinars.

Want access without creating an account?

   

You have 1 free members-only resource remaining this month.

1 free members-only resources remaining

1 free members-only resources remaining

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

This content is available through your Curated Research partnership with Advisory Board. Click on ‘view this resource’ to read the full piece

Email ask@advisory.com to learn more

Click on ‘Become a Member’ to learn about the benefits of a Full-Access partnership with Advisory Board

Never miss out on the latest innovative health care content tailored to you. 

Benefits Include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

This is for members only. Learn more.

Click on ‘Become a Member’ to learn about the benefits of a Full-Access partnership with Advisory Board

Never miss out on the latest innovative health care content tailored to you. 

Benefits Include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
AB
Thank you! Your updates have been made successfully.
Oh no! There was a problem with your request.
Error in form submission. Please try again.